Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Search for reporting guidelines

Use your browser's Back button to return to your search results

EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Reporting comparative effectiveness research using observational data in rheumatology
Full bibliographic reference Courvoisier DS, Lauper K, Kedra J, de Wit M, Fautrel B, Frisell T, Hyrich KL, Iannone F, Machado PM, Ørnbjerg LM, Rotar Z, Santos MJ, Stamm TA, Stones SR, Strangfeld A, Bergstra SA, Landewé RBM, Finckh A. EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Ann Rheum Dis. 2022;81(6):780-785.
Language English
PubMed ID 35058229
Relevant URLs
(full-text if available)
Read the full-text of this reporting guideline.
Study design Observational studies
Clinical area Rheumatology
Applies to the whole report or to individual sections of the report? Data, Harms/adverse effects/safety data, Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.)
Record last updated on May 17, 2022

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

We have also translated some of our website pages into other languages:
EQUATOR resources in Spanish
EQUATOR resources in Portuguese
EQUATOR resources in German

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.